History

The Narrative, Restitched

In December 2023 Micron was still booking GAAP losses, writing down inventory, and pleading for patience after a downturn it called the worst since the financial crisis. By March 2026 it guided to $33.5B of quarterly revenue at ~81% non-GAAP gross margin — a setup with no precedent in memory. The pivot was not luck: management called the AI/HBM thesis early, repeated it quarter after quarter, and then delivered against an escalating sequence of its own promises (HBM market-share parity by CY25, sold-out HBM books for 2024 then 2025 then 2026, multi-year supply agreements with hyperscalers in FY26). The credibility blemishes are real but narrow — a securities class action over consumer/NAND demand commentary in 2023–24 (since dismissed and withdrawn) and the late-FY25 decision to stop giving full-year revenue guidance even as the cycle inflected up — but they are dwarfed by a track record of beats that grew from "above guide" to "double the guide."

1. The Narrative Arc

The arc reads in three acts. FY23 trough (pre-window): inventory writedowns, China CAC ban hits ~a quarter of revenue, 15% headcount cut, bonuses suspended. FY24 reset: the AI/HBM message becomes the whole pitch in the first quarter and never wavers; gross margin moves from negative to 36.5% in four quarters. FY25–FY26 takeoff: HBM scales, supply tightens across the industry, pricing reflects shortage, and the company ends up guiding to a quarterly revenue figure (>$33B) larger than its FY23 full year ($15.5B).

2. What Management Emphasized — and Then Stopped Emphasizing

Topic emphasis on earnings calls (intensity 0 = absent, 5 = dominant):

Three patterns matter. HBM/AI rises from "an opportunity" to the entire investment thesis — by FY26 every other talking point is downstream of it. Inventory and pricing-discipline language quietly disappears: in FY24 the company spent paragraphs explaining how it was choking off supply; by FY26 the message is the opposite — "we are short to demand." Long-term supply agreements emerge as a brand-new pillar in FY25/FY26, culminating in the first signed SCA disclosed in 2Q26, framed as a hedge against the next downturn ("visibility and stability around the business model"). Note also what is not on the chart: 3D XPoint, the Lehi facility, and the IMFT joint venture with Intel — strategic dead-ends from earlier eras now fully retired from the narrative.

3. Risk Evolution

Risk-factor emphasis in 10-K, FY21–FY25 (0 = absent, 5 = lead risk):

Four shifts stand out. COVID drops out completely between FY22 and FY23 — a clean exit, no lingering language. Geopolitical risk replaces it as the new top external concern, escalating each year as US export controls and (most concretely) the May 2023 China Cyberspace Administration ban remove a low-double-digit percentage of revenue. Capex returns and government-incentive clawback risk become first-order, reflecting the Boise (Idaho) and Clay (NY) megafabs and the contingencies attached to CHIPS Act funding. AI risk gets named for the first time in FY25 — in part as a positive demand driver, in part because customer concentration in a small set of hyperscalers is now a structural exposure. The IMFT JV legacy and any 3D XPoint follow-through are gone.

4. How They Handled Bad News

The two genuine "bad news" episodes inside this window were (a) the cycle trough in FY23 and (b) the unexpected sequential revenue decline guided in 1Q25 (Dec 2024) on consumer/NAND weakness.

The FY23 trough was handled with operational decisiveness — restructuring, cost cuts, capex discipline — and the recovery pitch ("AI is structurally different") proved correct. The 2Q25 guide-down is the more interesting credibility test: management had spent the prior three quarters describing PC and smartphone inventories as "normalizing" and was caught when that thesis broke. They acknowledged it cleanly on the call. A securities class action was later filed covering March 29, 2023 – December 18, 2024 alleging that consumer-market and NAND-inventory commentary was overly optimistic; the U.S. District Court for Idaho dismissed the case on February 3, 2026 and plaintiffs voluntarily withdrew on April 3, 2026.

5. Guidance Track Record

The sequence of beats is the cleanest single piece of evidence on management's credibility. Across ten consecutive quarters (1Q24 through 2Q26) Micron beat its own non-GAAP revenue guide every quarter, and beat its non-GAAP EPS guide every quarter — usually by progressively larger margins.

Score: 9 / 10. Earned by: nine consecutive revenue beats, nine consecutive EPS beats, the HBM parity-by-CY25 promise delivered on schedule (Q3 CY25), the "HBM sold out for 2024 / 2025 / 2026" claim re-validated three years running, and the $100B HBM TAM by 2028 forecast (pulled in two years from prior outlook). Reasons it isn't 10: (a) the 2Q25 guide-down was a real miss against the prior-quarter narrative even though the related class action was later dismissed, and (b) the decision in FY26 to stop offering full-year revenue guidance even while beating quarterly guides by 28% — defensible, but it removes a useful accountability mechanism.

6. What the Story Is Now

The story today is no longer "Micron is recovering from the worst memory downturn in a decade." It is "Micron has structurally repositioned the mix of its business toward AI-driven data center memory — most prominently HBM — at exactly the moment when industry supply is constrained by physics (clean-room build times, declining bits-per-wafer on advanced nodes, and an HBM trade ratio that is moving from ~3:1 toward 4:1 as HBM4/4E ramp)." Management's framing has shifted from cyclical defense (cost cuts, inventory discipline) to structural offense (greenfield fabs in Boise and Clay NY, multi-year supply contracts with hyperscalers, $25B+ FY26 capex with FY27 expected higher).

What has been de-risked: the AI demand thesis (now corroborated by every hyperscaler capex print); the HBM share question (parity achieved, with HBM4 sampling well); and the trough question (FY26 quarterly revenue exceeds FY23 full-year revenue).

What still looks stretched: the 81% gross margin guide for 3Q26 implies a pricing environment that has historically been impossible to sustain in memory — even Micron's CFO conceded this on the 2Q26 call. The China CAC ban is still in place and tariff/Section 232 risk is rising. Customer concentration in a handful of GPU/ASIC platforms is now a real exposure. And the company is committing tens of billions of dollars of capex to capacity that won't ship bits until 2027–28, on the assumption that today's AI-memory shortage persists.

What the reader should believe: the operational record (technology leadership, HBM execution, manufacturing ramp) and the through-cycle competitive position. Mehrotra has been right on the big calls for three straight years.

What to discount: any forecast that treats today's gross margin as a steady state. Memory has always mean-reverted, and the only question is when — not whether. The SCAs are designed precisely to dampen that reversion; whether they will is unknown until the next downcycle. Until then, take the financial trajectory at face value, but mentally haircut the long-term margin assumption.